"Causal Evaluation of Post-Marketing Drugs for Drug-induced Liver Injury ..."

Yu Wang et al. (2023)

> Home

Details and statistics

DOI: 10.1109/EMBC40787.2023.10340721

access: closed

type: Conference or Workshop Paper

metadata version: 2025-10-14

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - conf/embc/WangMMWL23
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/embc/WangMMWL23
Yu Wang, Jing Ma, Shuang Ma, Jiaqi Wang, Jingsong Li:
Causal Evaluation of Post-Marketing Drugs for Drug-induced Liver Injury from Electronic Health Records. EMBC 2023: 1-4

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.